JellyBlue Ingredients: Seven Actives, Seven Printed Amounts

The largest single amount on this panel, and the one the whole formula is built around: 200 mg is nearly a third of the 650 mg of actives in a gummy. A Malaysian root, used there as a tonic long before anyone ran a trial on it, and one of very few botanicals in this category with a modern randomised record. Set beside the trials: a 2022 meta-analysis of tongkat ali trials pooled clinical trials of standardised extract and reported a rise in serum total testosterone; the arms it drew on ran 200 to 400 mg a day. A six-month randomised trial in older men gave 400 mg a day to men with age-related androgen decline. So 200 mg sits at the bottom of the studied range rather than outside it, which is not true of anything else on this label. The standing pharmacology and toxicology review of tongkat ali is the reference summary of what the root is and how it has been tested.

A cruciferous root grown above 4,000 metres in the Peruvian Andes, eaten there as a food - which is the first thing to know about the amount, because food-scale use is what the trials copied. Set beside the trials: the 12-week maca trial in healthy men gave 1,500 mg and 3,000 mg a day for twelve weeks and reported improved self-rated sexual desire from week eight, with no change in serum testosterone or oestradiol - a finding worth keeping, because it means maca is not on this label as a hormone ingredient whatever the sales page implies. A systematic review of the maca trials reached the same cautious conclusion across the literature. A 12-week trial of black and red maca ran 3,000 mg a day. Against a floor of 1,500 mg, 100 mg is a fifteenth of the smallest amount anybody has studied.

The classical Ayurvedic adaptogen and the best-researched name on the panel, included here for the reason it is usually included: for a great many men in their forties the thing draining the tank is chronic stress and short sleep rather than anything a botanical addresses directly. Note the panel spells it “Ashwaganda”. Set beside the trials: an eight-week ashwagandha trial in overweight men aged 40 to 70 gave 600 mg a day of a standardised root extract. A randomised trial of ashwagandha in stressed adults used 240 mg a day for sixty days, and it is the lowest daily amount in this literature with a result attached. A meta-analysis of ashwagandha's hormonal effects pools the trials that measured hormones. At 100 mg the gummy is between two and a half and six times short, and extract strength is not stated, so even that ratio is a best case rather than a measurement.

The botanical this category is named for as often as not, and the one with the widest gap between reputation and evidence. Its marker compound, icariin, is genuinely interesting in the laboratory. What does not exist is a randomised human trial of the herb for this use case to point a reader at, and it would be dishonest to imply otherwise. The panel spells it “Horney goat weed”. What does exist is the standardisation work on Epimedium, and its finding is the practical one - content varies enormously between species and between batches, so “100 mg of Epimedium extract” does not describe a fixed quantity of anything. This is also the ingredient behind the interaction note on the side effects page.

First on the panel, and the ingredient the sales copy leans on hardest for its blood-flow story, because the nitric-oxide story is easy to tell. L-arginine is a precursor the body converts to nitric oxide, which relaxes the smooth muscle in blood-vessel walls. The chemistry is real. The amount is the problem. Set beside the trials: the arms pooled in a network meta-analysis of supplement ingredients for erectile function run from 1,500 mg to 5,000 mg a day. Fifty milligrams is a thirtieth of the bottom of that range and a hundredth of the top. Arginine is also an ordinary part of any protein-containing meal, so whatever this gummy does, it is not doing it through its arginine line.

The ingredient the advertising leaves out. Beet root is on the printed panel at 50 mg and appears nowhere in the seller’s ingredient list or on its sales page. It is also, by a distance, the ingredient on this label whose pathway to blood flow has been measured most often in people: dietary nitrate from beet is reduced to nitrite by microbes that live at the back of the tongue, and that nitrite becomes nitric oxide once it is in the bloodstream - the same end point the L-arginine paragraph above is selling, reached by a route that works at food doses. Set beside the trials: the beetroot juice trial that opened this literature gave 500 mL of beetroot juice, roughly 22.5 mmol of nitrate, and measured a fall in blood pressure within hours. A meta-analysis of beetroot nitrate and blood pressure and a 2026 meta-analysis of longer-term nitrate supplementation pool the trials that followed, most of which sit around 5 to 6 mmol a day. Those are juice-glass and concentrate amounts; 50 mg of an extract of unstated strength does not reach them. The interesting thing is not that the amount is small - most of them are - but that the best-evidenced name on the bottle is the one the marketing department dropped.

The last line on the panel and the quietest ingredient in the formula. Grape seed carries oligomeric proanthocyanidins, polyphenols studied mostly for what they do to the lining of blood vessels rather than for anything about drive or energy. Set beside the trials: a dose-response meta-analysis of grape seed extract pooled controlled trials measuring flow-mediated dilation, blood pressure and heart rate; a meta-analysis of sixteen grape seed trials looks at blood pressure alone. The arms in both run from 100 to 800 mg a day, with most clustered between 150 and 300. At 50 mg this is between a half and a sixteenth of a studied amount, and it is here for the same reason grape seed is on a hundred other labels: it is cheap, it is well tolerated, and it reads well on a list.